IS2783B - Lyfjasamsetning sem nær yfir kító-fáliður - Google Patents

Lyfjasamsetning sem nær yfir kító-fáliður

Info

Publication number
IS2783B
IS2783B IS7193A IS7193A IS2783B IS 2783 B IS2783 B IS 2783B IS 7193 A IS7193 A IS 7193A IS 7193 A IS7193 A IS 7193A IS 2783 B IS2783 B IS 2783B
Authority
IS
Iceland
Prior art keywords
oligomers
chitosomes
covers
pharmaceutical composition
treatment
Prior art date
Application number
IS7193A
Other languages
English (en)
Other versions
IS7193A (is
Inventor
Jon M Einarsson
Johannes Gislason
Martin Peter
Sven Bahrke
Original Assignee
Genis Ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genis Ehf filed Critical Genis Ehf
Publication of IS7193A publication Critical patent/IS7193A/is
Publication of IS2783B publication Critical patent/IS2783B/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Materials Engineering (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IS7193A 2001-09-26 2004-03-22 Lyfjasamsetning sem nær yfir kító-fáliður IS2783B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum
PCT/IS2002/000016 WO2003026677A1 (en) 2001-09-26 2002-09-26 Pharmaceutical composition comprising chito-oligomers

Publications (2)

Publication Number Publication Date
IS7193A IS7193A (is) 2004-03-22
IS2783B true IS2783B (is) 2012-05-15

Family

ID=36700489

Family Applications (2)

Application Number Title Priority Date Filing Date
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum
IS7193A IS2783B (is) 2001-09-26 2004-03-22 Lyfjasamsetning sem nær yfir kító-fáliður

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum

Country Status (13)

Country Link
US (2) US7985741B2 (is)
EP (1) EP1435976B1 (is)
JP (1) JP4613008B2 (is)
KR (1) KR20040062548A (is)
AT (1) ATE359797T1 (is)
CA (1) CA2507926C (is)
DE (1) DE60219653T2 (is)
DK (1) DK1435976T3 (is)
ES (1) ES2284935T3 (is)
IS (2) IS6085A (is)
PT (1) PT1435976E (is)
SI (1) SI1435976T1 (is)
WO (1) WO2003026677A1 (is)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050070500A1 (en) * 2001-12-13 2005-03-31 Boucher L Isabelle Method of modulating release of saccharides and uses thereof
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
JP2007507516A (ja) * 2003-10-01 2007-03-29 オプティマー・ファーマスーティカルズ・インコーポレイテッド アミノ糖投与による哺乳動物の障害の治療及びアミノ糖の使用
US20070082851A1 (en) * 2003-11-24 2007-04-12 Optimer Pharmaceuticals Inc. Treatment of a condition in a mammal with administration of Compounds and Methods of Use
CA2551613A1 (en) * 2004-05-21 2005-12-01 Tottori University A composition comprising n-acetyl-d-glucosamine for treatment of wound
MX336736B (es) * 2005-06-14 2016-01-29 Genis Hf Composiciones de derivados de quitina parcialmente desacetilados.
US7485718B2 (en) 2005-06-16 2009-02-03 E. I. Du Pont De Nemours And Company Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
WO2007001282A2 (en) * 2005-06-16 2007-01-04 E.I. Dupont De Nemours And Company Low molecular weight polyglucosamines and polygalactosamines
KR100831335B1 (ko) * 2006-06-22 2008-05-22 부경대학교 산학협력단 인간 피부 섬유아세포에서 메트릭스메탈로프로테이나제-2의 발현 및 활성을 억제시키는키토올리고사카라이드 화합물 및 이를 함유한 메트릭스메탈로프로테이나제-2 억제제
EP2318014B1 (en) * 2008-07-18 2016-09-14 Genís hf. New composition for treating autoimmune disorders
KR20100060634A (ko) * 2008-11-28 2010-06-07 (주)아모레퍼시픽 미토콘드리아 활성화를 위한 조성물
KR101729137B1 (ko) * 2009-07-28 2017-04-26 (주)아모레퍼시픽 키토올리고당을 함유하는 피로회복용 조성물
US9186377B2 (en) 2011-06-03 2015-11-17 Maguire Abbey, Llc Method, composition, and articles for improving joint lubrication
EP3058826A1 (en) 2011-09-08 2016-08-24 Novozymes BioAG A/S Seed treatment methods and compositions
PL2748123T3 (pl) 2011-09-14 2024-05-13 Novozymes Bioag A/S Zastosowanie lipochito-oligosacharydów i/lub chito-oligosacharydów w kombinacji z mikroorganizmami solubilizującymi fosforany do poprawy wzrostu roślin
AU2012312006B2 (en) * 2011-09-23 2015-10-29 Novozymes Bioag A/S Chitooligosaccharides and methods for use in enhancing corn growth
CA2849898C (en) 2011-09-23 2020-10-27 Novozymes Bioag A/S Chitooligosaccharides and methods for use in enhancing plant growth
US9474828B2 (en) 2012-04-23 2016-10-25 Genis Hf. Self-hardening bioactive cement compositions with partially deacetylated chitin as bone graft substitutes
JP6285497B2 (ja) * 2016-06-07 2018-02-28 株式会社エバーライフ 鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法
KR101673368B1 (ko) 2016-07-14 2016-11-08 김기혁 공정가스 반응물의 콜드트랩 장치
EP4511042A4 (en) * 2022-04-21 2026-04-22 Therapeutikos Inc METHODS OF TREATING INFLAMMATION

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5919122B2 (ja) * 1976-10-12 1984-05-02 味の素株式会社 水溶性部分脱アセチル化キチン及びその製造法
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JP2527317B2 (ja) * 1986-12-19 1996-08-21 ライオン株式会社 骨疾患治療剤
US6184037B1 (en) * 1996-05-17 2001-02-06 Genemedicine, Inc. Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
DE69733089T2 (de) * 1996-12-13 2005-09-29 Lescarden Inc. Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin
JP3062592B2 (ja) * 1997-05-30 2000-07-10 農林水産省食品総合研究所長 2−アセチルアミノ−4−O−(2−アミノ−2−デオキシ−β−D −グルコピラノシル)−2−デオキシ−D −グルコースおよびその塩の製造法
US6492350B2 (en) * 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
EP1127574A1 (en) * 2000-02-22 2001-08-29 Food Industry Research and Development Institute Use of chitinous materials for inhibiting cellular nitric oxide production
CA2313836C (en) * 2000-03-15 2009-06-09 Cargill, Incorporated Chitosan and method of preparing chitosan
US20020119949A1 (en) 2001-02-26 2002-08-29 Asa Hellman Prophylactic teat treatment
MX336736B (es) * 2005-06-14 2016-01-29 Genis Hf Composiciones de derivados de quitina parcialmente desacetilados.

Also Published As

Publication number Publication date
EP1435976A1 (en) 2004-07-14
US8415326B2 (en) 2013-04-09
ES2284935T3 (es) 2007-11-16
US20110257381A1 (en) 2011-10-20
SI1435976T1 (sl) 2007-08-31
ATE359797T1 (de) 2007-05-15
DE60219653D1 (de) 2007-05-31
DE60219653T2 (de) 2008-01-03
JP4613008B2 (ja) 2011-01-12
PT1435976E (pt) 2007-06-28
WO2003026677A1 (en) 2003-04-03
IS7193A (is) 2004-03-22
CA2507926C (en) 2011-12-20
US20050004073A1 (en) 2005-01-06
DK1435976T3 (da) 2007-08-27
JP2005507891A (ja) 2005-03-24
US7985741B2 (en) 2011-07-26
EP1435976B1 (en) 2007-04-18
CA2507926A1 (en) 2003-04-03
KR20040062548A (ko) 2004-07-07
IS6085A (is) 2003-03-27

Similar Documents

Publication Publication Date Title
SI1435976T1 (sl) Farmacevtski sestavek, ki obsega hito-oligomere
IL150257A0 (en) Galactomaninan oligosaccharides, pharmaceutical compositions containing the same and methods for the production thereof
WO2004105737A3 (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
PT1319183E (pt) Métodos e produtos relacionados a heparina de baixo peso molecular
MXPA04001876A (es) Uso de fucanos en el tratamiento de adhesiones, artritis y psoriasis.
NO20012000D0 (no) N-(2-aryl-propionyl)-sulfonamider og farmasöytiske sammensetninger som inneholder dem
MXPA05011098A (es) Composicion de polisacaridos entrelazados.
DZ3165A1 (fr) Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie.
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
FI20011403A7 (fi) Menetelmä ja koostumukset vatsan sairauksien hoitoon
MY142376A (en) Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
NO20056161L (no) Formuleringer for behandling av artrittilstander
CA2474511A1 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
MXPA04001686A (es) Combinaciones de productos activos fungicidas.
JP2005507891A5 (is)
IS6914A (is) 2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum
YU67900A (sh) Sukcinamidni inhibitori interleukin-1beta konvertujućeg enzima
ITMI20021801A1 (it) Prodotti di pomodoro.
ID28365A (id) Turunan produk alami yang baru
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
IT1318432B1 (it) Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
WO2005011611A3 (en) Bicyclic compounds and compositions as pdf inhibitors
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv
DK1301192T3 (da) Anvendelse af polysulfaterede cyclodextriner til behandling af artrose
ATE552004T1 (de) Oral verabreichbare heparinderivate